TW200731970A - Enhanced efficacy benzisoxazole derivative dosage forms and methods - Google Patents

Enhanced efficacy benzisoxazole derivative dosage forms and methods

Info

Publication number
TW200731970A
TW200731970A TW095138307A TW95138307A TW200731970A TW 200731970 A TW200731970 A TW 200731970A TW 095138307 A TW095138307 A TW 095138307A TW 95138307 A TW95138307 A TW 95138307A TW 200731970 A TW200731970 A TW 200731970A
Authority
TW
Taiwan
Prior art keywords
methods
dosage forms
enhanced efficacy
benzisoxazole derivative
derivative dosage
Prior art date
Application number
TW095138307A
Other languages
Chinese (zh)
Inventor
Michelle Kramer
Peter Briscoe
Sandra Boom
An Vermeulen
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38734884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200731970(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/262,113 external-priority patent/US20060189635A1/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of TW200731970A publication Critical patent/TW200731970A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed are dosage forms and methods comprising benzisoxazole derivatives. More particularly, disclosed are dosage forms, methods, and new uses of benzisoxazole derivatives that provide enhanced efficacy when used in the treatment of schizophrenia and/or bipolar mainia.
TW095138307A 2005-10-19 2006-10-18 Enhanced efficacy benzisoxazole derivative dosage forms and methods TW200731970A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72862005P 2005-10-19 2005-10-19
US11/262,113 US20060189635A1 (en) 2005-02-04 2005-10-27 Enhanced efficacy benzisoxazole derivative dosage forms and methods

Publications (1)

Publication Number Publication Date
TW200731970A true TW200731970A (en) 2007-09-01

Family

ID=38734884

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138307A TW200731970A (en) 2005-10-19 2006-10-18 Enhanced efficacy benzisoxazole derivative dosage forms and methods

Country Status (5)

Country Link
AR (1) AR057161A1 (en)
GT (1) GT200600467A (en)
PE (1) PE20071028A1 (en)
TW (1) TW200731970A (en)
UY (1) UY29877A1 (en)

Also Published As

Publication number Publication date
GT200600467A (en) 2007-09-21
AR057161A1 (en) 2007-11-21
PE20071028A1 (en) 2007-11-30
UY29877A1 (en) 2006-12-29

Similar Documents

Publication Publication Date Title
TW200637522A (en) Skin treatment articles and methods
MX2008011633A (en) Aminoquinolones as gsk-3 inhibitors.
MX349787B (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor.
MX2009000285A (en) Substituted piperidines that increase p53 activity and the uses thereof.
MX2009006536A (en) Organic compounds and their uses.
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
MY165570A (en) Inhibitors of poly (adp-ribose) polymerase
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
TNSN08400A1 (en) Organic compounds and their uses
WO2007081878A8 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
EP2192901A4 (en) Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
UA106367C2 (en) Azadispiro[3.0.4.1]decane derivatives and their uses
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
TW200716088A (en) Formulations and methods for treating amyloidosis
PL1919466T3 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative
HK1121936A1 (en) Methods and compositions using immunomodulatory compounds for the treatment of disorders associated with low plasma leptin levels
HK1162502A1 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3
WO2007047608A3 (en) Fibrin targeted therapeutics
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
EP1686986A4 (en) Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
CY1111762T1 (en) OUTDOOR OUTDOOR OLANZAPIN
WO2005000192A3 (en) Glycogen synthase kinase-3 inhibitors
RS54185B1 (en) Use of 24-norudca
TW200716561A (en) P38 inhibitors and methods of use thereof